If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Do-Youn Oh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 52 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Biliary Tract Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 8474 Citations
  • 42 h-Index
  • 272 Article
  • 7 Review article
  • 3 Comment/debate
  • 1 Editorial

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer

Park, H., Bang, J. H., Nam, A. R., Eun Park, J., Hua Jin, M., Bang, Y. J. & Oh, D-Y., 1 Dec 2019, In : Scientific Reports. 9, 1, 11131.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Pancreatic Neoplasms
Ligands
Drug Therapy
Disease Progression
Tumor Microenvironment

Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients

Lee, D. W., Ryu, H. S., Jin, M. S., Lee, K. H., Suh, K. J., Youk, J., Kim, J. Y., Min, A., Lee, H. B., Moon, H. G., Kim, T. Y., Han, S-W., Oh, D-Y., Han, W., Park, I., Noh, D. & Im, S-A., 30 Jul 2019, In : British Journal of Cancer. 121, 3, p. 230-236 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Breast Neoplasms
Recurrence
Proteins
Biomarkers
Tumor-Infiltrating Lymphocytes
1 Citation (Scopus)

Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients

Kim, J. Y., Lee, D. W., Lee, K-H., Min, A., Ryu, H. S., Lee, H-B., Moon, H. G., Kim, T-Y., Han, S-W., Oh, D-Y., Han, W., Park, I., Noh, D., Im, S-A. & Kim, S., 30 Jul 2019, In : Breast Cancer Research and Treatment. 176, 2, p. 453-460 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Body Mass Index
Hormones
Breast Neoplasms
Thinness
Neoplasms
2 Citations (Scopus)

Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer

Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J. O., Hochhauser, D., Arnold, D., Oh, D-Y., Reinacher-Schick, A., Tortora, G., Algül, H., O'Reilly, E. M., McGuinness, D., Cui, K. Y., Schlienger, K., Locker, G. Y. & Kindler, H. L., 25 Jul 2019, In : New England Journal of Medicine. 381, 4, p. 317-327 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Pancreatic Neoplasms
Maintenance
Placebos
Quality of Life
Confidence Intervals

Jab1 silencing inhibits proliferation and sensitizes to cisplatin in biliary tract cancer

Nam, A. R., Kim, J. W., Park, J. E., Bang, J. H., Jin, M. H., Oh, D-Y. & Bang, Y. J., 1 Jul 2019, In : Cancer Research and Treatment. 51, 3, p. 886-900 15 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Biliary Tract Neoplasms
Cisplatin
Small Interfering RNA
G1 Phase Cell Cycle Checkpoints
DNA Damage